Evidence map›Paper›PMID 42237289›Full record

Observational studyMalaria journal2026

Ten years of Plasmodium malariae infections in an International Health Reference Center in Barcelona: temporal trends and insights.

Arantxa Pérez-Ugarte, Elena Sulleiro, Jana Rovira-Plujà, Merve Bayram, Francesc Zarzuela, Carles Rubio Maturana, Núria Serre-Delcor, María Luisa Aznar, Diana Pou, Lidia Goterris and 9 more

Abstract readObservational Study
In one paragraph

Observational study in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Arantxa Pérez-UgarteDepartment of Genetics and Microbiology, Universitat Autònoma de Barcelona, Barcelona, Spain.
Elena SulleiroDepartment of Genetics and Microbiology, Universitat Autònoma de Barcelona, Barcelona, Spain. elena.sulleiro@vallhebron.cat.
Jana Rovira-PlujàMicrobiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Merve BayramVall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain.
Francesc ZarzuelaVall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain.
Carles Rubio MaturanaMicrobiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Núria Serre-DelcorVall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain.
María Luisa AznarVall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain.
Diana PouVall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain.
Lidia GoterrisMicrobiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Fernando SalvadorVall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain.
Alejandro MediavillaMicrobiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Pau BoschVall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain.
Joan Martinez-CampreciósVall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain.
Begoña TreviñoVall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain.
Patricia Martínez-VallejoMicrobiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Aroa SilgadoMicrobiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Israel Molina *Vall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain.
Inés Oliveira-Souto *Vall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, International Health Programme of Catalan Health Institute (PROSICS) Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain. ines.oliveira@vallhebron.cat.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPlasmodium malariae remains one of the most neglected human malaria parasites. Historically considered of low prevalence and limited clinical significance, emerging evidence suggests its true burden may be underestimated due to diagnostic challenges and the parasite's ability to persist at low densities.

methodsA retrospective observational study was conducted at the Vall d'Hebron-Drassanes International Health Unit (Barcelona) from June 2015 to May 2025. Malaria diagnosis was performed using microscopy or quantitative PCR (qPCR), with the diagnostic method selected according to clinical presentation and epidemiological risk. Clinical and epidemiological data were collected and analyzed by descriptive statistics.

resultsAmong 6,293 individuals screened for malaria, 404 (6.4%; CI 95%: 5.8-7.1) were positive for Plasmodium spp., of whom 55 (13.6%; CI 95%: 10.6-17.3) were infected with P. malariae. Most infections (52/55; 94.5%) were detected in asymptomatic migrants from sub-Saharan Africa during routine screening, with very low parasite densities (≤ 80 parasites/µL). Notably, 13/55 patients had been living in Spain for more than 12 months prior to diagnosis, supporting long-term persistence of low-level parasitemia. Furthermore, one symptomatic traveler, experienced a clinical relapse after artemisinin-based combination therapy.

conclusionsThis study describes the trend in the diagnosis of P. malariae at a referral center in a non-endemic European setting. The high proportion of asymptomatic chronic carriers underscores a silent parasite reservoir that may hinder malaria elimination efforts. Increased awareness and improved diagnostic strategies are needed to better characterize and control this overlooked species.

Indexed as

MalariaPlasmodium malariaeAdolescentAdultAgedChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedPrevalenceRetrospective StudiesSpainYoung Adult

Identifiers

PMID42237289
PMCPMC13455210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.